pillbase.ru

Pramipexole Dihydrochloride

Active substance: pramipexole

TABLET · PRAMIPEXOLE DIHYDROCHLORIDE .125 mg/1

United StatesActive

Marketing holder: Alembic Pharmaceuticals Limited

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 6
  • Mirapexin
    pramipexole dihydrochloride monohydrate
    EMEA/H/C/000134
    Boehringer Ingelheim International GmbH
  • Oprymea
    pramipexole dihydrochloride monohydrate
    EMEA/H/C/000941
    Krka, d.d., Novo mesto
  • Pramipexole Teva
    pramipexole dihydrochloride monohydrate
    EMEA/H/C/000940
    Teva Pharma B.V.
  • Sifrol
    pramipexole
    EMEA/H/C/000133
    Boehringer Ingelheim International GmbH
  • Daquiran
    pramipexole dihydrochloride monohydrate
    EMEA/H/C/000135
    Dr. Karl Thomae GmbH
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-48a9-75be-85f1-2d9c63860547,01a1208c-4ad5-773f-8881-65d9f19912fc,01a1208c-5075-7b58-a3d8-18d2529991a7,01a1208c-622e-7259-bea6-42d0d01c890c,01a1208c-6273-72f7-88e9-4d1dab690adc;count=137 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
46708-611
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 46708-611 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 46708-611 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 46708-611 · Verified 2026-10-09 · open in source